Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 9 de 9
Filter
Add more filters










Database
Language
Publication year range
1.
Biomed Environ Sci ; 36(2): 127-134, 2023 Feb 20.
Article in English | MEDLINE | ID: mdl-36861191

ABSTRACT

Objective: This study was aimed at investigating the carrier rate of, and molecular variation in, α- and ß-globin gene mutations in Hunan Province. Methods: We recruited 25,946 individuals attending premarital screening from 42 districts and counties in all 14 cities of Hunan Province. Hematological screening was performed, and molecular parameters were assessed. Results: The overall carrier rate of thalassemia was 7.1%, including 4.83% for α-thalassemia, 2.15% for ß-thalassemia, and 0.12% for both α- and ß-thalassemia. The highest carrier rate of thalassemia was in Yongzhou (14.57%). The most abundant genotype of α-thalassemia and ß-thalassemia was -α 3.7/αα (50.23%) and ß IVS-II-654/ß N (28.23%), respectively. Four α-globin mutations [CD108 (ACC>AAC), CAP +29 (G>C), Hb Agrinio and Hb Cervantes] and six ß-globin mutations [CAP +8 (C>T), IVS-II-848 (C>T), -56 (G>C), beta nt-77 (G>C), codon 20/21 (-TGGA) and Hb Knossos] had not previously been identified in China. Furthermore, this study provides the first report of the carrier rates of abnormal hemoglobin variants and α-globin triplication in Hunan Province, which were 0.49% and 1.99%, respectively. Conclusion: Our study demonstrates the high complexity and diversity of thalassemia gene mutations in the Hunan population. The results should facilitate genetic counselling and the prevention of severe thalassemia in this region.


Subject(s)
Hemoglobinopathies , alpha-Thalassemia , beta-Thalassemia , Humans , beta-Thalassemia/epidemiology , beta-Thalassemia/genetics , alpha-Thalassemia/epidemiology , alpha-Thalassemia/genetics , Hemoglobinopathies/epidemiology , Hemoglobinopathies/genetics , China/epidemiology , High-Throughput Nucleotide Sequencing
2.
Nat Commun ; 12(1): 1354, 2021 Mar 01.
Article in English | MEDLINE | ID: mdl-33649344

ABSTRACT

Covalent organic frameworks have recently gained increasing attention in photocatalytic hydrogen generation from water. However, their structure-property-activity relationship, which should be beneficial for the structural design, is still far-away explored. Herein, we report the designed synthesis of four isostructural porphyrinic two-dimensional covalent organic frameworks (MPor-DETH-COF, M = H2, Co, Ni, Zn) and their photocatalytic activity in hydrogen generation. Our results clearly show that all four covalent organic frameworks adopt AA stacking structures, with high crystallinity and large surface area. Interestingly, the incorporation of different transition metals into the porphyrin rings can rationally tune the photocatalytic hydrogen evolution rate of corresponding covalent organic frameworks, with the order of CoPor-DETH-COF < H2Por-DETH-COF < NiPor-DETH-COF < ZnPor-DETH-COF. Based on the detailed experiments and calculations, this tunable performance can be mainly explained by their tailored charge-carrier dynamics via molecular engineering. This study not only represents a simple and effective way for efficient tuning of the photocatalytic hydrogen evolution activities of covalent organic frameworks at molecular level, but also provides valuable insight on the structure design of covalent organic frameworks for better photocatalysis.

3.
Chem Soc Rev ; 49(24): 9028-9056, 2020 Dec 21.
Article in English | MEDLINE | ID: mdl-33135701

ABSTRACT

Facile activation and conversion of small molecules (e.g., H2O, CO2, N2, CH4, and C6H6) into solar fuels or value-added chemicals under mild conditions is an attractive pathway in dealing with the worldwide appeal of energy consumption and the growing demand of industrial feedstocks. Compared with conventional thermo- or electro-catalytic approaches, the protocol of photocatalysis shines light on green and low-cost storage of sunlight in chemical bonds. For instance, artificial photosynthesis is an effective way to split H2O into molecular O2 and H2, thereby storing solar energy in the form of hydrogen fuel. Because of rational tunability in band gaps, charge-carrier dynamics, exposed active sites and catalytic redox activities by tailoring size, composition, morphology, surface, and/or interface property, semiconductor nanocrystals (NCs) emerge as very promising candidates for photo-induced small molecule activation, including H2O splitting, CO2 reduction, N2 fixation, CH4 conversion and chemical bond formation (e.g., S-S, C-C, C-N, C-P, C-O). In this review, we summarize the recent advances in small molecule activation via artificial photosynthesis using semiconductor NCs, especially those consisting of II-VI and III-V elements. Moreover, we highlight the intrinsic advantages of semiconductor NCs in this field and look into the fabrication of prototype devices for large-scale and sustainable small molecule activation to store solar energy in chemical bonds.

4.
J Am Chem Soc ; 142(10): 4680-4689, 2020 Mar 11.
Article in English | MEDLINE | ID: mdl-32066243

ABSTRACT

Semiconductor quantum dots (QDs) in conjunction with non-noble 3d-metal ions (e.g., Fe3+, Co2+, and Ni2+) have emerged as an extremely efficient, facile, and cost-effective means of solar-driven hydrogen (H2) evolution. However, the exact structural change of the active sites under realistic conditions remains elusive, and the mechanism of H2 evolution behind the remarkable activity is poorly understood. Here, we successfully track the structural variation of the catalytic sites in the typical H2 photogeneration system consisting of CdSe/CdS QDs and 3d-metal ions (i.e., Ni2+ used here). That is, the nickel precursor of Ni(OAc)2 changes to Ni(H2O)62+ in neutral H2O and eventually transforms to Ni(OH)2 nanosheets in alkaline media. Furthermore, the in operando spectroscopic techniques of electron paramagnetic resonance and X-ray absorption spectroscopy reveal the photoinduced transformation of Ni(OH)2 to a defective structure [Nix0/Ni1-x(OH)2], which acts as the real catalytic species of H2 photogeneration. Density functional theory (DFT) calculations further indicate that the surface Ni-vacancies (VNi) on the Ni(OH)2 nanosheets enhance the adsorption and dissociation of H2O molecules to enhance the local proton concentration, while the Ni0 clusters behave as H2-evolution sites, thereby synergistically promoting the activity of H2 photogeneration in alkaline media.

5.
Sci Rep ; 7: 40013, 2017 01 03.
Article in English | MEDLINE | ID: mdl-28045138

ABSTRACT

Cyclin-dependent kinase 5 (CDK5) is a multifaceted protein shown to play important roles in the central nervous system. Abundant evidence indicates that CDK5 hyperactivities associated with neuronal apoptosis and death following ischemic stroke. CDK5 activity increases when its cofactor p35 cleaves into p25 during ischemia. Theoretically, inhibition of CDK5/p25 activity or reduction of p25 would be neuroprotective. TFP5, a modified 24-aa peptide (Lys254-Ala277) derived from p35, was found to effectively inhibit CDK5 hyperactivity and improve the outcomes of Alzheimer's disease and Parkinson's disease in vivo. Here, we showed that intraperitoneal injection of TFP5 significantly decreased the size of ischemia in early-stage of adult ischemic stroke rats. Relative to controls, rats treated with TFP5 displayed reduced excitotoxicity, neuroinflammation, apoptosis, astrocytes damage, and blood-brain barrier disruption. Our findings suggested that TFP5 might serve as a potential therapeutic candidate for acute adult ischemic stroke.


Subject(s)
Neuroprotective Agents/therapeutic use , Peptides/therapeutic use , Stroke/drug therapy , Animals , Apoptosis/drug effects , Astrocytes/drug effects , Astrocytes/pathology , Blood-Brain Barrier/drug effects , Brain/pathology , Cyclin-Dependent Kinase 5/metabolism , Disease Models, Animal , Infarction, Middle Cerebral Artery/complications , Male , Matrix Metalloproteinase 9/blood , Neurons/drug effects , Neurons/metabolism , Neuroprotective Agents/pharmacology , Peptides/pharmacology , Protein Subunits/metabolism , Rats , Rats, Sprague-Dawley , Receptors, N-Methyl-D-Aspartate/metabolism , Stroke/etiology , Stroke/pathology , Stroke/prevention & control
6.
Cryobiology ; 72(2): 141-7, 2016 Apr.
Article in English | MEDLINE | ID: mdl-26802735

ABSTRACT

This study aimed to identify optimal mild hypothermic (MH) condition that would provide the best protection for neuronal cells undergoing severe ischemia and hypoxia. We also sought to determine if longer exposure to mild hypothermia would confer greater protection to severe ischemia and hypoxia in these cells. We designed a primary neuronal cell model for severe glucose and oxygen deprivation/reoxygenation (OGD/R) to simulate the hypoxic-ischemic condition of patients with severe stroke, trauma, or hypoxic-ischemic encephalopathy. We evaluated the viability of these neurons following 3 h of OGD/R and variable MH conditions including different temperatures and durations of OGD/R exposure. We further explored the effects of the optimal MH condition on several parts which are associated with mitochondrial apoptosis pathway: intracellular calcium, reactive oxygen species (ROS), and mitochondrial transmembrane potential (MTP). The results of this study showed that the apoptosis proportion (AP) and cell viability proportion (CVP) after OGD/R significantly varied depending on which MH condition cells were exposed to (p < 0.001). Further, our findings showed that prolonged MH reduced the neuroprotection to AP and CVP. We also determined that the optimal MH conditions (34 °C for 4.5 h) reduced intracellular calcium, ROS, and recovered MTP. These findings indicate that there is an optimal MH treatment strategy for severely hypoxia-ischemic neurons, prolonged duration might diminish the neuroprotection, and that MH treatment likely initiates neuroprotection by inhibiting the mitochondrial apoptosis pathway.


Subject(s)
Cell Hypoxia/physiology , Hypothermia, Induced/methods , Hypothermia/physiopathology , Neurons/cytology , Neuroprotection/physiology , Animals , Apoptosis/physiology , Calcium/metabolism , Cell Survival/physiology , Cells, Cultured , Glucose/metabolism , Hypothermia/metabolism , Membrane Potential, Mitochondrial , Mitochondria/metabolism , Models, Animal , Neurons/physiology , Oxygen/metabolism , Rats , Rats, Sprague-Dawley , Reactive Oxygen Species/metabolism
8.
Sci Rep ; 4: 7091, 2014 Nov 18.
Article in English | MEDLINE | ID: mdl-25404538

ABSTRACT

Co-treatment of neuroprotective reagents may improve the therapeutic efficacy of hypothermia in protecting neurons during ischemic stroke. This study aimed to find promising drugs that enhance the neuroprotective effect of mild hypothermia (MH). 26 candidate drugs were selected based on different targets. Primary cultured cortical neurons were exposed to oxygen-glucose deprivation and reoxygenation (OGD/R) to induce neuronal damage, followed by either single treatment (a drug or MH) or a combination of a drug and MH. Results showed that, compared with single treatment, combination of MH with brain derived neurotrophic factor, glibenclamide, dizocilpine, human urinary kallidinogenase or neuroglobin displayed higher proportion of neuronal cell viability. The latter three drugs also caused less apoptosis rate in combined treatment. Furthermore, co-treatment of those three drugs and MH decreased the level of reactive oxygen species (ROS) and intracellular calcium accumulation, as well as stabilized mitochondrial membrane potential (MMP), indicating the combined neuroprotective effects are probably via inhibiting mitochondrial apoptosis pathway. Taken together, the study suggests that combined treatment with hypothermia and certain neuroprotective reagents provide a better protection against OGD/R-induced neuronal injury.


Subject(s)
Dizocilpine Maleate/pharmacology , Globins/pharmacology , Kallikreins/pharmacology , Nerve Tissue Proteins/pharmacology , Neurons/drug effects , Neuroprotective Agents/pharmacology , Animals , Animals, Newborn , Apoptosis/drug effects , Calcium/metabolism , Cell Survival/drug effects , Cerebral Cortex/drug effects , Cerebral Cortex/metabolism , Cerebral Cortex/pathology , Cold Temperature , Combined Modality Therapy , Culture Media/chemistry , Glucose/deficiency , Membrane Potential, Mitochondrial/drug effects , Mitochondria/drug effects , Mitochondria/metabolism , Neuroglobin , Neurons/metabolism , Neurons/pathology , Oxygen/pharmacology , Primary Cell Culture , Rats , Rats, Sprague-Dawley , Reactive Oxygen Species/antagonists & inhibitors , Reactive Oxygen Species/metabolism , Reperfusion Injury/therapy
9.
J Biomed Biotechnol ; 2012: 803930, 2012.
Article in English | MEDLINE | ID: mdl-23193366

ABSTRACT

The study explored a modified primary culture system for fetal rat cortical neurons. Day E18 embryos from pregnant Sprague Dawley rats were microdissected under a stereoscope. To minimize enzymatic damage to the cultured neurons, we applied a sequential digestion protocol using papain and Dnase I. The resulting sifted cell suspension was seeded at a density of 50,000 cells per cm(2) onto 0.1 mg/mL L-PLL-covered vessels. After a four-hour incubation in high-glucose Dulbecco's Modified Eagle's Medium (HG-DMEM) to allow the neurons to adhere, the media was changed to neurobasal medium that was refreshed by changing half of the volume after three days followed by a complete medium change every week. The cells displayed progressively robust neurite extension, and nonneuronal-like cells could barely be detected by five days in vitro (DIV); cell growth was still substantial at 14 DIV. Neurons were identified by ß-tubulin III immunofluorescence, and neuronal purity within the cultures was assessed at over 95% by both flow cytometry and by dark-field counting of ß-tubulin III-positive cells. These results suggest that the protocol was successful and that the high purity of neurons in this system could be used as the basis for generating various cell models of neurological disease.


Subject(s)
Cell Culture Techniques/methods , Cerebral Cortex/cytology , Cerebral Cortex/embryology , Fetus/cytology , Neurons/cytology , Animals , Cells, Cultured , Craniotomy , Dissection , Female , Fetus/blood supply , Fluorescent Antibody Technique , Indoles/metabolism , Neurons/metabolism , Rats , Rats, Sprague-Dawley , Skull/surgery , Tubulin/metabolism
SELECTION OF CITATIONS
SEARCH DETAIL
...